BPC-157: what thousands of people report, and why that matters
Three small trials. Ten years of collected human experience, 16,000 cases. The second is the largest body of evidence on this peptide, and the one almost nobody reads.
Three small trials. Ten years of collected human experience, 16,000 cases. The second is the largest body of evidence on this peptide, and the one almost nobody reads.
FLOW gave weekly semaglutide or placebo to 3,533 adults with type 2 diabetes and kidney disease. Major kidney events were 24% less likely on semaglutide.
STEP 8 put semaglutide and liraglutide side by side in one phase 3 trial. At 68 weeks average weight fell 15.8% on semaglutide and 6.4% on liraglutide.
STEP 5 followed 304 adults for two years. Average weight fell 15.2% on semaglutide 2.4 mg against 2.6% on placebo, and the loss held steady after about week 60.
A purity figure is a share, not an identity. Vials have passed 99% purity screens while containing a different compound entirely, and the report looked perfect.
No certificate is not automatically a red flag, but an unverifiable one is. Here is the short list of questions that separates the two.
Every supplier selling tested peptides says so. The difference between a claim and a proof is a task number, a verification page and a lot that matches.
Blood markers of a man 20 years younger. Sleep fixed, energy fixed, every single marker optimal. I'm in the best health of my life at over 50 years old. So to also look the best I ever have in my life is a massive bonus.
Training with injuries felt like a ceiling I'd never break through. Just three months in, strength up 60%, body composition transformed, and injuries resolved. The results have blown away my expectation.
My ex-coaches said gaining muscle and losing fat at the same time was impossible. It turned out to be more than possible. And to be ageing at only 0.6 years per year and have a metabolic age seven and a half years younger than myself — to say I'm chuffed is an understatement.